Canada markets closed

Treatment.com AI Inc. (TRUE.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
0.6900-0.0100 (-1.43%)
At close: 03:58PM EDT
Full screen
Previous Close0.7000
Open0.7100
Bid0.6800 x N/A
Ask0.7100 x N/A
Day's Range0.6800 - 0.7400
52 Week Range0.1000 - 1.2000
Volume169,934
Avg. Volume59,306
Market Cap25.603M
Beta (5Y Monthly)-0.22
PE Ratio (TTM)N/A
EPS (TTM)-0.2200
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    Treatment.com AI partners with aiXplain Inc. to extend access to its Global Library of Medicine (GLM)

    VANCOUVER, British Columbia, April 10, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Treatment”) is pleased to announce it has signed a Collaborative Agreement with aiXplain, Inc. (“aiXplain”) to enable greater access to Treatment’s proprietary Global Library of Medicine (“GLM”) by contributing to aiXplain’s ever-growing dynamic Artificial Intelligence (AI) marketplace. Treatment has partnered with aiXplain, the industry’s first no-code/low-code integra

  • GlobeNewswire

    Treatment.com AI welcomes the Federal Government's announcement of a plan to fund $2.4 billion in its upcoming budget towards Artificial Intelligence (AI) Adoption

    VANCOUVER, British Columbia, April 08, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (the “Company” or “Treatment”) welcomes Prime Minister Justin Trudeau’s announcement on 7th April, 2024, that the federal government plans to fund $2.4 billion in its upcoming budget towards build capacity in Artificial Intelligence (AI) adoption. The federal government’s announcement indicates an imminent consultation with industry on a new AI Compute Access Fund and an

  • GlobeNewswire

    Treatment.com AI Funded by the National Institute of Health to Develop a Culturally Sensitive AI Approach to Health Equity

    VANCOUVER, British Columbia, March 27, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (the “Company” or “Treatment”) is pleased to announce that the Company has received funding from The National Institute of Health (“NIH”) to develop a culturally sensitive AI approach for collecting family medical history. Treatment has partnered with Rush River Research in Minneapolis to develop an Artificial Intelligence (AI) approach for collecting information about fa